Oncgnostics GmbH:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Oncgnostics GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10460
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that offers development of in-vitro diagnostic tests for the therapeutics area of cancer. The company’s pipeline products include GynTect technology a system based on the detection of epigenetic biomarkers mainly in the methylation of specific DNA regions. Its GynTect also allows a fast and reliable detection of cervical precancerous lesions and cancer. Oncgnostics’ pipeline focuses on applications in the fields that include ovarian cancer and head-and-neck tumors, among others. The company also provides IVD test development field after test validation and initial preclinical trials, and others. Oncgnostics is headquartered in Jena, Germany.

Oncgnostics GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oncgnostics GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oncgnostics GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Oncgnostics GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oncgnostics GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Oncgnostics GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Oncgnostics GmbH, Medical Equipment, Deal Details 10
Venture Financing 10
Oncgnostics Raises USD1 Million in Seed Financing 10
Oncgnostics Raises USD1.1 Million in Series A Financing 11
Oncgnostics Raises Funds Through Seed Financing 12
Partnerships 13
MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 13
Sinopharm Enters into Licensing Agreement with Oncgnostics 14
Oncgnostics Enters into Co-Marketing Agreement with Greiner Bio-One 15
Oncgnostics GmbH – Key Competitors 16
Oncgnostics GmbH – Key Employees 17
Oncgnostics GmbH – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Oncgnostics GmbH, Medical Equipment, Key Facts 2
Oncgnostics GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Oncgnostics GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oncgnostics GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Oncgnostics GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oncgnostics GmbH, Deals By Market, 2012 to YTD 2018 8
Oncgnostics GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Oncgnostics Raises USD1 Million in Seed Financing 10
Oncgnostics Raises USD1.1 Million in Series A Financing 11
Oncgnostics Raises Funds Through Seed Financing 12
MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 13
Sinopharm Enters into Licensing Agreement with Oncgnostics 14
Oncgnostics Enters into Co-Marketing Agreement with Greiner Bio-One 15
Oncgnostics GmbH, Key Competitors 16
Oncgnostics GmbH, Key Employees 17

List of Figures
Oncgnostics GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Oncgnostics GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Oncgnostics GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Oncgnostics GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Oncgnostics GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oncgnostics GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Oncgnostics GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oncgnostics GmbH, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Oncgnostics GmbH:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bel Fuse, Inc.:企業の戦略・SWOT・財務分析
    Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Samsung Securities Co., Ltd. (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co., Ltd. (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Five Star Senior Living Inc (FVE):製薬・医療:M&Aディール及び事業提携情報
    Summary Five Star Senior Living Inc (Five Star), formerly Five Star Quality Care Inc is a healthcare service provider that offers senior living and patient care services. The center’s services include independent living, assisted living, skilled nursing care, memory care, dining and nutrition, hospi …
  • Mead Johnson Nutrition Company:企業の戦略・SWOT・財務情報
    Mead Johnson Nutrition Company - Strategy, SWOT and Corporate Finance Report Summary Mead Johnson Nutrition Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Qisda Corporation:戦略・SWOT・企業財務分析
    Qisda Corporation - Strategy, SWOT and Corporate Finance Report Summary Qisda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • QNB Finansbank (FINBN):企業の財務・戦略的SWOT分析
    QNB Finansbank (FINBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Berkeley Energia Ltd:企業の戦略・SWOT・財務分析
    Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report Summary Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Holloway Lodging Corporation:戦略・SWOT・企業財務分析
    Holloway Lodging Corporation - Strategy, SWOT and Corporate Finance Report Summary Holloway Lodging Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Charkit Chemical Corp:戦略・SWOT・企業財務分析
    Charkit Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary Charkit Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alfa Group Consortium:企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Rongsheng Petrochemical Co Ltd (002493):企業の財務・戦略的SWOT分析
    Summary Rongsheng Petrochemical Co Ltd (Rongsheng), a subsidiary of Zhejiang Rongsheng Holding Group Co Ltd is a chemical company that produces and distributes PTA, polyester fiber and chemical products. The company’s products include synthetic fibers and films, synthetic raw material, synthetic res …
  • Northwest Biotherapeutics Inc (NWBO)-医療機器分野:企業M&A・提携分析
    Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated with the normal chemotherapy drugs. The company by utilizing its proprietary technology plat …
  • Harbor MedTech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Harbor MedTech Inc (Harbor MedTech) is a commercial-stage regenerative medicine company that offers tissue regeneration solutions. The company offers Architect, an extracellular collagen matrix used in managing partial and full thickness wounds. Its collagen wound matrix systems are used in …
  • General Dynamics Corporation:企業の戦略・SWOT・財務情報
    General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • China NT Pharma Group Co Ltd (1011):製薬・医療:M&Aディール及び事業提携情報
    Summary China NT Pharma Group Co Ltd (NT Pharma) is a technology-based pharmaceutical company, which researches, develops, manufactures, and distributes branded and generic pharmaceuticals. The company also promotes and distributes drugs manufactured by third parties. It develops drugs for indicatio …
  • Broadcom Inc:企業の戦略・SWOT・財務情報
    Broadcom Inc - Strategy, SWOT and Corporate Finance Report Summary Broadcom Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ovid Therapeutics Inc (OVID):製薬・医療:M&Aディール及び事業提携情報
    Summary Ovid Therapeutics Inc (Ovid Therapeutics) is a bio-pharmaceutical company which identifies, discovers, and develops medicines for neurological disorders. The company’s pipeline products are indicated for diseases such as Angelman Syndrome and Fragile X Syndrome. It develops, assess, commerci …
  • Samba Financial Group (1090):企業の財務・戦略的SWOT分析
    Samba Financial Group (1090) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ludwig Institute For Cancer Research Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Ludwig Institute for Cancer Research Ltd (LICR) is a non-profit organization that conducts cancer research and clinical trial programs. The organization carries out research in the areas of clinical trials, genomics, cell biology, immunology, neuroscience, signaling, therapeutics, stem cells …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆